Related Experiment Video
Updated: Dec 13, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
MDMX phosphorylation-dependent p53 downregulation contributes to an immunosuppressive tumor microenvironment
Bing Wang1,2,3, Chuan-Bian Lim3, Jiawei Yan3
1Key Laboratory of Space Radiobiology of Gansu Province & Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Abstract:
A role of tumor-suppressive activity of p53 in the tumor microenvironment (TME) has been implicated but remains fairly understudied. To address this knowledge gap, we leveraged our MdmxS314A mice as recipients to investigate how implanted tumor cells incapacitate host p53 creating a conducive TME for tumor progression. We found that tumor cell-associated stress induced p53 downregulation in peritumor cells via an MDMX-Ser314 phosphorylation-dependent manner. As a result, an immunosuppressive TME was developed, as reflected by diminished immune cell infiltration into tumors and compromised macrophage M1 polarization. Remarkably, ablation of MDMX-Ser314 phosphorylation attenuated p53 decline in peritumor cells, which was associated with mitigation of immunosuppression and significant tumor growth delay. Our data collectively uncover a novel role of p53 in regulating the tumor immune microenvironment, suggesting that p53 restoration in the TME can be exploited as a potential strategy of anticancer therapy.
Insights
The tumor microenvironment (TME) plays a crucial role in cancer progression. This study reveals how targeting p53 in the TME can enhance anti-cancer therapy by restoring immune function.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The tumor-suppressive role of p53 within the tumor microenvironment (TME) is understudied.
- Understanding how tumors manipulate host p53 to create a pro-tumorigenic TME is critical.
Purpose of the Study:
- To investigate how implanted tumor cells affect host p53 within the TME.
- To explore the impact of p53 downregulation on immune cell activity and tumor progression.
- To evaluate the therapeutic potential of modulating p53 activity in the TME.
Main Methods:
- Utilized MdmxS314A mice as recipients for implanted tumor cells.
- Analyzed p53 downregulation in peritumor cells induced by tumor cell-associated stress.
- Assessed immune cell infiltration and macrophage polarization within the TME.
- Investigated the effect of ablating MDMX-Ser314 phosphorylation on p53 levels and TME immunosuppression.
Main Results:
- Tumor cells induced p53 downregulation in peritumor cells via MDMX-Ser314 phosphorylation.
- This p53 decline resulted in an immunosuppressive TME with reduced immune cell infiltration and M1 macrophage polarization.
- Ablating MDMX-Ser314 phosphorylation mitigated p53 decline, reduced immunosuppression, and delayed tumor growth.
Conclusions:
- p53 plays a novel role in regulating the tumor immune microenvironment.
- Restoring p53 activity within the TME presents a potential anticancer therapeutic strategy.
- Targeting the MDMX-Ser314 phosphorylation pathway offers a means to modulate p53 and enhance anti-tumor immunity.
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

